NCT05684263 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Fairburn CG, Beglin SJ
Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord. 1994 Dec;16(4):363-70.
Laliberte MM, Newton M, McCabe R, & Mills JS
Controlling Your Weight Versus Controlling Your Lifestyle: How Beliefs about Weight Control Affect Risk for Disordered Eating, 10534_2006_9060_Fig3_HTML.gif Dissatisfaction and Self-esteem. Cognitive Therapy and Research. 2007; 31(6): 853-869.
Rosenberg M
Society and the Adolescent Self-Image (Revised edition). Wesleyan University Press. 1989.
Tylka TL, Wood-Barcalow NL
The Body Appreciation Scale-2: item refinement and psychometric evaluation. Body Image. 2015 Jan;12:53-67. doi: 10.1016/j.bodyim.2014.09.006. Epub 2014 Oct 21.
Wilkerson AH, Hackman CL, Rush SE, Usdan SL, Smith CS
"Drunkorexia": Understanding eating and physical activity behaviors of weight conscious drinkers in a sample of college students. J Am Coll Health. 2017 Oct;65(7):492-501. doi: 10.1080/07448481.2017.1344848. Epub 2017 Jun 22.

An Experimental Study of the Effects of Weight Science and Nutrition Education on Weight Control Beliefs and Disordered Eating in a Non-clinical Female Sample.

Details for clinical trial NCT05684263

Clinical trial NCT05684263 - References